Somatic inactivation of the VHL gene in Von Hippel-Lindau disease tumors

American Journal of Human Genetics

Volumn 60, Issue 4, 1997, Pages 765-771

  Prowse, Amanda H ^a   Webster, Andrew R ^a,b   Richards, Frances M ^a   Richard, Stephane ^c   Olschwang, Sylviane ^d   Resche, François ^e   Affara, Nabeel A ^a   Maher, Eamonn R ^a,f  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d INSTITUT CURIE   (France)

^e NANTES UNIVERSITY HOSPITAL   (France)

^f UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CARCINOGENESIS; FAMILIAL CANCER; FEMALE; GENE ACTIVATION; GENE LOCUS; GENETIC ANALYSIS; HEMANGIOBLASTOMA; HUMAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; METHYLATION; MISSENSE MUTATION; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; RETINA TUMOR; TUMOR SUPPRESSOR GENE; VON HIPPEL LINDAU DISEASE;

CHROMOSOME DELETION; DNA METHYLATION; DNA, NEOPLASM; GENES, TUMOR SUPPRESSOR; HIPPEL-LINDAU DISEASE; HUMANS; LIGASES; MODELS, BIOLOGICAL; MUTATION; NEOPLASMS; PROTEINS; SEQUENCE ANALYSIS, DNA; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 0031004284     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Aso T, Lane WS, Conaway JW, Conaway RC (1995) Elongin (SIII): a multisubunit regulator of elongation by RNA polymerase II. Science 269:1439-1443
2. Brauch H, Kishida T, Glavac D, Chen F, Pausch F, Hofler H, Latif F, et al (1995) von Hippel Lindau disease with pheochromocytoma in the Black Forest region of Germany: evidence for a founder effect. Hum Genet 95:551-556
3. Chen F, Kishida T, Yao M, Hustad T, Glavac D, Dean D, Gnarra JR, et al (1995) Germline mutations in the von Hippel Lindau disease tumor suppressor gene: correlations with phenotype. Hum Mutat 5:66-75
4. Crossey PA, Eng C, Ginalska-Malinowska M, Lennard TWJ, Wheeler DC, Ponder BAJ, Maher ER (1995) Molecular genetic diagnosis of von Hippel-Lindau disease in familial pheochromocytoma. J Med Genet 32:885-886
5. Crossey PA, Foster K, Richards FM, Phipps ME, Latif F, Tory K, Jones MH, et al (1994a) Molecular genetic investigation of the mechanism of tumorigenesis in von Hippel-Lindau disease: analysis of allele loss in VHL tumors. Hum Genet 93:53-58
6. Crossey PA, Richards FM, Foster K, Green JS, Prowse A, Latif F, Lerman MI, et al (1994b) Identification of intragenic mutations in the von Hippel-Lindau disease tumor suppressor gene and correlation with disease phenotype. Hum Mol Genet 3:1303-1308
7. Decker HJ, Klauck SM, Lawrence JB, McNeil J, Smith D, Gemmill RM, Sandberg AA, et al (1994) Cytogenetic and fluorescence in situ hybridization studies on sporadic and hereditary tumors associated with von Hippel-Lindau syndrome (VHL). Cancer Genet Cytogenet 77:1-13
8. Duan DR, Pause A, Burgess WH, Aso T, Chen DYT, Garrett KP, Conaway RC, et al (1995) Inhibition of transcription elongation by the VHL tumor suppressor protein. Science 269:1402-1406
9. Eng C, Crossey PA, Mulligan LM, Healey CS, Houghton C, Prowse A, Chew SL, et al (1995) Mutations in the RET proto-oncogene and the von Hippel-Lindau disease tumor suppressor gene in sporadic and syndromic pheochromocytomas. J Med Genet 32:934-937
10. Foster K, Osborne RJ, Huddart RA, Affara NA, Ferguson-Smith MA, Maher ER (1995) Molecular genetic analysis of the von Hippel-Lindau disease (VHL) tumor suppressor gene in gonadal tumors. Eur J Cancer 31:392-395
11. Foster K, Prowse A, van den Berg A, Fleming S, Hulsbeek MMF, Crossey PA, Richards FM, et al (1994) Somatic mutations of the von Hippel-Lindau disease tumor suppressor gene in nonfamilial clear cell renal carcinoma. Hum Mol Genet 3:2169-2173
12. Gnarra JR, Tory K, Weng Y, Schmidt L, Wei MH, Li H, Latif F, et al (1994) Mutations of the VHL tumor suppressor gene in renal carcinoma. Nat Genet 7:85-90
13. Herman JG, Latif F, Weng Y, Lerman MI, Zbar B, Liu S, Samid D, et al (1994) Silencing of the VHL tumor suppressor gene by DNA methylation in renal carcinomas. Proc Natl Acad Sci USA 91:9700-9704
14. Kanno H, Kondo K, Ito S, Yamamoto I, Fujii S, Torigoe T, Sakai N, et al (1994) Somatic mutations of the von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangioblastomas. Cancer Res 54:4845-4847
15. Kibel A, Iliopoulos O, DeCaprio JA, Kaelin WG (1995) Binding of the von Hippel-Lindau tumor suppressor protein to elongin B and C. Science 269:1444-1446
16. Laird PW, Jaenisch R (1994) DNA methylation and cancer. Hum Mol Genet 3:1487-1495
17. Latif F, Tory K, Gnarra J, Yao M, Duh F-M, Orcutt ML, Stackhouse T, et al (1993) Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 260:1317-1320
18. Maher ER, Webster AR, Richards FM, Green JS, Crossey PA, Payne SJ, Moore AT (1996) Phenotypic expression in von Hippel-Lindau disease: correlations with germline VHL gene mutations. J Med Genet 33:328-332
19. Maher ER, Yates JRW, Harries R, Benjamin C, Harris R, Ferguson-Smith MA (1990) Clinical features and natural history of von Hippel-Lindau disease. Q J Med 77:1151-1163
20. Marshall CJ (1991) Tumor suppressor genes. Cell 64:313-326
21. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB, et al (1995) 5′ CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/MTS1 in human cancers. Nat Med 1: 686-692
22. Neumann HPH, Eng C, Mulligan L, Glavac D, Ponder BAJ, Crossey PA, Maher ER, et al (1995) Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia type 2. JAMA 274:1149-1151
23. Payne S, Richards FM, Maher ER (1994) PCR polymorphism in the 3′ UTR of the von Hippel-Lindau disease tumor suppressor gene. Hum Mol Genet 3:390
24. Seizinger BR, Klinger HP, Junien C, Nakamura Y, le Beau M, Cavanee W, Emanuel B, et al (1991) Report of the committee on chromosome and gene loss in human neoplasia. Cytogenet Cell Genet 58:1080-1096
25. Sekido Y, Bader S, Latif F, Gnarra JR, Gazdar AF, Linehan WM, Zbar B, et al (1994) Molecular analysts of the von Hippel-Lindau disease tumor suppressor gene in human lung cancer cell lines. Oncogene 9:1599-1604
26. Shuin T, Kondo K, Torigoe S, Kishida T, Kubota Y, Hosaka M, Nagashima Y, et al (1994) Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas. Cancer Res 54:2852-2855